Development of a Patient Decision Aid for cT1 Renal Masses: A User-Centered Mixed-Methods Study
We systematically developed a PtDA for cT1 renal masses. The PtDA was found acceptable and usable by patients and HCPs. The PtDA is currently being implemented in routine care.
Authors
- Harm H.E. van Melick (ORCID: https://orcid.org/0000-0001-9285-0632)
- Mirjam M. Garvelink (ORCID: https://orcid.org/0000-0001-5616-0597)
- P. B. van der Nat (ORCID: https://orcid.org/0000-0002-0990-073X)
- Regina The (ORCID: https://orcid.org/0000-0002-4258-3983)
- Cato C Bresser
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- St. Antonius Ziekenhuis (NL)
- ZorgKeuzeLab (NL)
- TropIQ Health Sciences (NL)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1097/upj.0000000000000830
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Mylan
- Stichting Kwaliteitsgelden Medisch Specialisten
- Ministerio de Economía y Competitividad
- Ipsen